We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The possible FDA approval of a drug targeting the ...
In a recent study posted to the bioRxiv* preprint server, researchers evaluated the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated inflammatory marker interferon ...
An essential component of many viruses, including SARS-CoV-2, are proteases which cleave its own proteins as well as those in the cell. Many viruses rely on proteases to process polypeptides into ...
Research presented by Professor Cecilia Johansson of Imperial College London has linked early type I interferon signalling in ...
Photo taken on a light microscope of bone marrow derived dendritic cells generated for the study at the University of Kansas. LAWRENCE — A new paper from the University of Kansas overturns the idea ...
Editor’s Note (9/4/20): Understanding how the immune system goes awry in COVID-19 may help prevent the most severe and deadly cases. Earlier this year Scientific American explained how administering ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...
LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B ce ...
In severe cases of COVID-19, a person’s immune system throws everything it has at the coronavirus, but some of the weapons it lobs end up hurting the patient instead of fighting the virus. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback